{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:24:46Z","timestamp":1694625886208},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T00:00:00Z","timestamp":1144886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T00:00:00Z","timestamp":1144886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1038\/sj.leu.2404232","type":"journal-article","created":{"date-parts":[[2006,4,15]],"date-time":"2006-04-15T07:43:33Z","timestamp":1145087013000},"page":"1297-1298","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reply to Kremer M et al., The JAK2 V617F mutation occurs frequently in myelodysplastic\/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis"],"prefix":"10.1038","volume":"20","author":[{"given":"K","family":"Ohyashiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,4,13]]},"reference":[{"key":"BF2404232_CR1","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779\u20131790.","journal-title":"N Engl J Med"},{"key":"BF2404232_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","volume":"106","author":"DP Steensman","year":"2005","unstructured":"Steensman DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u2018atypical\u2019 myeloproliferative disorders and myelodysplastic syndromes. Blood 2005; 106: 1207\u20131209.","journal-title":"Blood"},{"key":"BF2404232_CR3","unstructured":"Kremer M, Horn T, Dechow T, Tzankov A, Quintanilla-Martinez L, Fend F . The JAK2 V617F mutation occurs frequently in myelodysplastic\/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis. Leukemia, in press."},{"key":"BF2404232_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2141.1981.tb07191.x","volume":"49","author":"C Sultan","year":"1981","unstructured":"Sultan C, Sigaux F, Imbert M, Reyes F . Acute myelodysplasia with myelofibrosis: a report of eight cases. Br J Haematol 1981; 49: 11\u201316.","journal-title":"Br J Haematol"},{"key":"BF2404232_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/1097-0142(19910701)68:1<178::AID-CNCR2820680131>3.0.CO;2-Q","volume":"68","author":"K Ohyashiki","year":"1991","unstructured":"Ohyashiki K, Sasao I, Ohyashiki JH, Murakami T, Iwabuchi A, Tauchi T et al. Clinical and cytogenetic characteristics of myelodysplastic syndrome developing myelofibrosis. Cancer 1991; 68: 178\u2013183.","journal-title":"Cancer"},{"key":"BF2404232_CR6","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1038\/sj.leu.2403989","volume":"19","author":"K Ohyashiki","year":"2005","unstructured":"Ohyashiki K, Aota Y, Akahane D, Gotoh A, Miyazawa K, Kimura Y et al. The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients. Leukemia. 2005; 19: 2359\u20132360.","journal-title":"Leukemia."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:32:01Z","timestamp":1648780321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,13]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["BF2404232"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404232","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,13]]},"assertion":[{"value":"13 April 2006","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}